Prince Akwasi Mensah

Array ( [id] => 133032 [patent_doc_number] => 07696220 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Methods for the treatment or inhibition of ileus' [patent_app_type] => utility [patent_app_number] => 10/171299 [patent_app_country] => US [patent_app_date] => 2002-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 14303 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696220.pdf [firstpage_image] =>[orig_patent_app_number] => 10171299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6462139 [patent_doc_number] => 20020150565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Treatment and prevention of reactive oxygen metabolite-mediated cellular damage' [patent_app_type] => new [patent_app_number] => 10/171018 [patent_app_country] => US [patent_app_date] => 2002-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11782 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20020150565.pdf [firstpage_image] =>[orig_patent_app_number] => 10171018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1348281 [patent_doc_number] => 06579859 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Control of protozoa and protozoan cysts that harbor legionella' [patent_app_type] => B1 [patent_app_number] => 10/165917 [patent_app_country] => US [patent_app_date] => 2002-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1857 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579859.pdf [firstpage_image] =>[orig_patent_app_number] => 10165917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1337718 [patent_doc_number] => 06593336 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-15 [patent_title] => 'Methods for treating irritable bowel syndrome' [patent_app_type] => B2 [patent_app_number] => 10/166401 [patent_app_country] => US [patent_app_date] => 2002-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4175 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593336.pdf [firstpage_image] =>[orig_patent_app_number] => 10166401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870684 [patent_doc_number] => 20030083374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'NAALADase inhibitors useful as pharmaceutical compounds and compositions' [patent_app_type] => new [patent_app_number] => 10/164553 [patent_app_country] => US [patent_app_date] => 2002-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 26516 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083374.pdf [firstpage_image] =>[orig_patent_app_number] => 10164553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1202846 [patent_doc_number] => 06720318 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-13 [patent_title] => 'Combination of cyamemazine and an atypical neuroleptic' [patent_app_type] => B2 [patent_app_number] => 10/164771 [patent_app_country] => US [patent_app_date] => 2002-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1639 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/720/06720318.pdf [firstpage_image] =>[orig_patent_app_number] => 10164771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688911 [patent_doc_number] => 20030032636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist' [patent_app_type] => new [patent_app_number] => 10/165196 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7418 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032636.pdf [firstpage_image] =>[orig_patent_app_number] => 10165196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178040 [patent_doc_number] => 20020156089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Use of CRF antagonists and related compositions' [patent_app_type] => new [patent_app_number] => 10/161816 [patent_app_country] => US [patent_app_date] => 2002-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21581 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156089.pdf [firstpage_image] =>[orig_patent_app_number] => 10161816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6474085 [patent_doc_number] => 20020151543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-17 [patent_title] => 'Compositions and methods employing R (-) fluoxetine and other active ingredients' [patent_app_type] => new [patent_app_number] => 10/158886 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7807 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20020151543.pdf [firstpage_image] =>[orig_patent_app_number] => 10158886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5908155 [patent_doc_number] => 20020143010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Compounds for treating fibromyalgia and chronic fatigue syndrome' [patent_app_type] => new [patent_app_number] => 10/159913 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6240 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20020143010.pdf [firstpage_image] =>[orig_patent_app_number] => 10159913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6744580 [patent_doc_number] => 20030021763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Method for the treatment and/or prophylaxis of diseases caused by IL-12' [patent_app_type] => new [patent_app_number] => 10/156771 [patent_app_country] => US [patent_app_date] => 2002-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3129 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20030021763.pdf [firstpage_image] =>[orig_patent_app_number] => 10156771 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6414390 [patent_doc_number] => 20020183373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Use of amino-isoxazolidone compounds for improvement of lexical priming' [patent_app_type] => new [patent_app_number] => 10/154478 [patent_app_country] => US [patent_app_date] => 2002-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6000 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183373.pdf [firstpage_image] =>[orig_patent_app_number] => 10154478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6414389 [patent_doc_number] => 20020183372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Use of amino-isoxazolidone compounds for facilitation of perceptual learning' [patent_app_type] => new [patent_app_number] => 10/154464 [patent_app_country] => US [patent_app_date] => 2002-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5998 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183372.pdf [firstpage_image] =>[orig_patent_app_number] => 10154464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537594 [patent_doc_number] => 20020193379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Compositions and methods for decreasing the risk of or preventing neural tube disorders in mammals' [patent_app_type] => new [patent_app_number] => 10/144767 [patent_app_country] => US [patent_app_date] => 2002-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6765 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193379.pdf [firstpage_image] =>[orig_patent_app_number] => 10144767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6839191 [patent_doc_number] => 20030036531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Use of lysophospholipids to inhibit mammalian phospholipase D' [patent_app_type] => new [patent_app_number] => 10/145458 [patent_app_country] => US [patent_app_date] => 2002-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5101 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036531.pdf [firstpage_image] =>[orig_patent_app_number] => 10145458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 951373 [patent_doc_number] => 06960577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-11-01 [patent_title] => 'Combination therapy for treatment of refractory depression' [patent_app_type] => utility [patent_app_number] => 10/144159 [patent_app_country] => US [patent_app_date] => 2002-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6582 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/960/06960577.pdf [firstpage_image] =>[orig_patent_app_number] => 10144159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005458 [patent_doc_number] => 06906054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-14 [patent_title] => 'Compositions for inhibiting beta-lactamase' [patent_app_type] => utility [patent_app_number] => 10/143636 [patent_app_country] => US [patent_app_date] => 2002-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18077 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/906/06906054.pdf [firstpage_image] =>[orig_patent_app_number] => 10143636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7337288 [patent_doc_number] => 20040132770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen' [patent_app_type] => new [patent_app_number] => 10/475867 [patent_app_country] => US [patent_app_date] => 2003-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10986 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132770.pdf [firstpage_image] =>[orig_patent_app_number] => 10475867 [rel_patent_id] =>[rel_patent_doc_number] =>)